Clinical Trials Logo
  1. Home
  2. Stable Coronary Artery Disease
  3. NCT06123728

MCG is Clinically Applied to Evaluate Myocardial Ischemic Function in Patients With Stable Coronary Artery Disease

Stable Coronary Artery Disease Clinical Trial

Official title:
The Clinical Application of Magnetocardiography (MCG) as a Non-invasive Diagnostic Tool for Evaluating Myocardial Ischemic Function in Patients With Stable Coronary Artery Disease

Clinical Trial Summary

The objective of this observational study is to evaluate the diagnostic effectiveness of magnetocardiography (MCG) in patients with stable coronary artery disease (SCAD) and compare it with coronary CTA (CCTA). Additionally, the study aims to determine the most suitable diagnostic index for MCG. The primary question it seeks to address is whether MCG or MCG combined with CCTA can be utilized to guide the clinical application of percutaneous coronary intervention (PCI) for coronary heart disease.

Clinical Trial Description

1. Patients agedā‰„18 years with stable coronary artery disease (CCTA stenosis 30%-90%) underwent sequential examinations of MCG and CCTA. The results of CCTA were assessed using CT-FFR, and the diagnostic effectiveness of MCG in evaluating myocardial ischemia was analyzed using CT-FFR as the reference standard. Simultaneously, MCG was compared to CCTA to determine the clinical value of MCG in the functional evaluation of myocardial ischemia. 2. Coronary angiography was performed in patients who met the criteria for the procedure, and revascularization was carried out based on the intraoperative situation. Patients who underwent revascularization were followed up for 1 year, with major adverse cardiovascular events (MACE) as the endpoint. The clinical value of MCG in guiding the treatment of patients with SCAD was evaluated by reviewing the proportion of coronary angiography, revascularization, and MACE in the enrolled patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06123728
Study type Observational [Patient Registry]
Source Nanhai Hospital, Guangdong Provincial People's Hospital
Contact Wenfei He
Phone 13380239072
Email nh2y_xnk@163.com
Status Recruiting
Phase
Start date April 19, 2023
Completion date February 2026
View Details
See also
  Status Clinical Trial Phase
Completed NCT01205425 - Computed Tomography Coronary Angiography Before Stent Implantation N/A
Completed NCT01243099 - Prospective Study to Assess DES Re-endothelization in BMS Restenosis and De-novo Lesions N/A
Completed NCT03312855 - Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous Revacept Phase 2
Completed NCT00642811 - A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders Phase 2
Recruiting NCT03089450 - To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent N/A
Completed NCT01523392 - A Pharmacodynamic Study With Ticagrelor in African American Patients Phase 4
Completed NCT01209637 - Impact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable CAD N/A
Active, not recruiting NCT04434365 - Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease Phase 1/Phase 2
Completed NCT00510588 - Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease N/A
Completed NCT03384966 - A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease Phase 2
Active, not recruiting NCT01609465 - Prognostic Models for People With Stable Coronary Artery Disease N/A
Terminated NCT00911339 - Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents Phase 3
Completed NCT00984802 - Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy Phase 2
Completed NCT03782688 - Precise Percutaneous Coronary Intervention Plan (P3) Study
Completed NCT02580851 - Magnetic Resonance Adenosine Perfusion Imaging as Gatekeeper of Invasive Coronary Intervention N/A
Recruiting NCT03313752 - Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity Phase 3
Completed NCT01184300 - ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation Phase 2/Phase 3
Completed NCT01523366 - A Pharmacodynamic Study With Ticagrelor in Hispanic Patients Phase 4
Completed NCT01118325 - An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease Phase 2